| |
| |
|
| Insider
Information: |
Becker Marc A. |
| Relationship: |
Chief Financial Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Concert Pharmaceuticals, Inc. |
CNCE |
Chief Financial Officer |
2023-03-06 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(49,699) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(56,264) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2023-02-15 |
4 |
AS |
$8.33 |
$31,337 |
D/D |
(3,762) |
123,863 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2023-01-30 |
4 |
AS |
$8.35 |
$70,917 |
D/D |
(8,493) |
127,625 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2023-01-06 |
4 |
AS |
$7.25 |
$20,974 |
D/D |
(2,893) |
136,118 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2022-02-14 |
4 |
AS |
$3.08 |
$11,587 |
D/D |
(3,762) |
139,011 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
81,600 |
142,773 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2022-01-05 |
4 |
AS |
$3.20 |
$9,261 |
D/D |
(2,894) |
61,173 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2021-08-16 |
4 |
AS |
$3.28 |
$23,957 |
D/D |
(7,304) |
64,067 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
AS |
$7.32 |
$27,545 |
D/D |
(3,763) |
71,371 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
21,700 |
75,134 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-08-17 |
4 |
AS |
$10.24 |
$29,440 |
D/D |
(2,875) |
53,434 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
28,216 |
56,309 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
CFO, PFO |
• – – |
2019-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
28,093 |
28,093 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
